Currently browsing category


The arms race of pharmaceutical advertising

Earlier this month, Derek Lowe’s In The Pipeline blog had some trenchant criticisms of a BMJ article (behind a paywall, alas) criticising the process of R&D in the pharmaceutical industry and questioning the supposedly huge costs of bringing a drug to market. I think Derek makes some excellent points, particularly …